A Na+-and C1-coupled serotonin (5-hydroxytryptamine, SHT) transporter is expressed on human neuronal, platelet, placental, and pulmonary membranes. The brain 5HT transporter appears to be a principal site of action of therapeutic antidepressants and may mediate behavioral and/or toxic effects of cocaine and amphetamines. Oligonucleotides derived from consensus transporter sequences were used to identify human placental cDNAs highly related to the rat brain 5HT carrier. Transfection of one of these cDNAs into HeLa cells yields a high-affinity (Km = 463 nM), Na+-and Cl--dependent 5HT transport activity which can be blocked by selective 5HT transport inhibitors, including paroxetine, fluoxetine, and imipramine, and which is antagonized by cocaine and amphetamine. Sequence analysis reveals a 630-amino acid open reading frame bearing 92% identity to the cloned rat brain 5HT transporter, with identical predicted topological features and conserved sites for posttranslational modifications. Unlike the rodent, where a single mRNA appears to encode 5HT transporters, multiple hybridizing RNAs are observed in human placenta and lung. Somatic cell hybrid and in situ hybridization studies are consistent, however, with a single gene encoding the human 5HT transporter, localized to chromosome 17q11.1-17q12.
synaptic neuronal membranes (3) (4) (5) . Transport of serotonin is exquisitely sensitive to nanomolar concentrations of tricyclic and heterocyclic antidepressants, including imipramine, fluoxetine, and paroxetine (6) , which are thought to bind directly to the 5HT carrier (7) (8) (9) (10) , presumably constituting the initial step in their therapeutic actions. In the periphery, platelet (11) , placental (12) , and pulmonary (13) plasma membranes exhibit a 5HT transporter whose ionic and pharmacologic sensitivities are highly similar to those described for the neuronal transporter. In particular, plasma membrane vesicle studies reveal central and peripheral 5HT carriers to be dependent upon extracellular Na+ and Cl-, stimulated by intracellular K+, and antagonized competitively by antidepressants (5, 11, (14) (15) (16) (17) . These properties serve to distinguish the plasma membrane 5HT transporter from the monoamine transporter present in intracellular secretory vesicles, which utilizes a transmembrane H+ gradient in an imipramine-insensitive, but reserpine-sensitive, manner to sequester amines, including 5HT, for release (18) .
The therapeutic utility of 5HT transport antagonists in the treatment of depression, obsessive-compulsive disorder, and sleep and eating disorders (19) has contributed to an emphasis on central serotonergic dysfunction within the monoamine theory of affective disorders (20) . While not a universal finding, reported reductions in platelet or brain 5HT transport and [3H]imipramine binding sites coincident with a diagnosis of major depression or obsessive-compulsive disorder, or following suicide, suggest that the 5HT transporter or its regulation may be altered in neuropsychiatric diseases (e.g., [21] [22] [23] . The gene(s) and protein(s) responsible for formation of a human 5HT transporter remain to be characterized.
Blakely et al. (9) and Hoffman et al. (10) identified cDNAs encoding rat brain and basophilic leukemia cell 5HT transporters, respectively. Sequence analysis of the cloned rat 5HT transporter cDNA (rSERT) establishes the carrier as a member of a large gene family encoding other Na+-and Cl--dependent transport proteins (24, 25) whose substrates include several neurotransmitters, such as -aminobutyric acid (GABA), norepinephrine, and dopamine, and substrates with either neuromodulatory or osmoprotective functions, including proline, glycine, and betaine. The rodent 5HT transporter is most closely related to human norepinephrine and rodent dopamine transporters, forming a small subdivision of biogenic amine transporters within the larger transporter family (25) , consistent with their marked overlap in antagonist (cocaine, antidepressant) sensitivities. Given the clinical significance of alterations in brain serotonergic function and the suggested alteration in 5HT transporter expression in depression and suicide, we have begun an investigation of the gene encoding the human SHT transporter. Here we provide the primary structure of a functional human 5HT transporter, document by transfection its sensitivity to monoamine and 5HT-selective transport antagonists, and examine the regional heterogeneity of hybridizing mRNAs.
Multiple exons appear to encode the human 5HT transporter gene, which we have mapped by using somatic cell hybrids and chromosomal in situ hybridization to chromosome 17q11.1-17q12.
MATERIALS AND METHODS
Poly(A)+ RNA, purified from a placental trophoblastic cell line (JAR; ref. 26) by the guanidinium isothiocyanate/cesium chloride method (27) , was converted to single-stranded cDNA (Superscript; GIBCO/BRL) and subjected to polymerase chain reaction (PCR) (28) , with Taq DNA polymerase Abbreviations: 5HT, 5-hydroxytryptamine (serotonin); GABA, y-aminobutyric acid.
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(Promega) for 30 cycles of 94°C, 1 min; 42°C, 2 min; 72°C, 3 min, with 10-min extension times programmed on cycles 1 and 30. Amplifications were conducted with degenerate oligodeoxynucleotides (5'-CCGCTCGAGAAYGTSTGGCGSTTYC-CNTA-3', 5'-GCTCTAGAGCTGRGTIGCRGCRTCRAKC-CA-3' , where Y = C orT; S = G orC; N = A, G, C, orT; R = A or G; and K = T or G) that were designed to encode highly conserved sequences of norepinephrine and GABA transporters and were previously employed for the identification of the rat brain 5HT and L-proline transporters (9, 29 Time (min) Concentration 5HT (pM) inhibition of norepinephrine transport [desipramine > > imipramine > amitriptyline (32) ]. The nonselective monoamine transport inhibitors cocaine and amphetamine blocked 5HT transport at low micromolar concentrations, with the cocaine analogue RTI-55 exhibiting increased potency over cocaine (Ki = 1 nM vs. 611 nM), as also described for the rat brain dopamine transporter (36) . The biogenic amines norepinephrine, dopamine, and histamine were only weak inhibitors of induced 5HT uptake, with Ki values > 10 ,uM. Thus, the transporter encoded by hSERT clearly exhibits the substrate selectivity, antagonist sensitivity, and ionic dependence of the 5HT carrier defined in human plasma membranes.
The 2508-bp cDNA sequence of the largest hSERT cDNA (Fig. 3) (Fig. 3 ) in perfect register with those identified in the rat transporter. The absence of a hydrophobic membrane insertion sequence (39) in the protein's amino terminus and a folding model to accommodate 12 transmembrane domains places both amino and carboxyl termini in the cytoplasm, as modeled for rSERT (9) .
The primary sequence of hSERT clarifies previous discrepancies in the reported structure of rat brain (9) 
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LG terminus, where 20 out of 52 differences occur, a region unlikely to contribute to substrate or antagonist selectivity (41) . Within the hSERT transmembrane domains, only domains 4, 9, and 12 exhibit multiple (and nonconservative) amino acid substitutions relative to rSERT. Tyrosine residues have been implicated in the Na+ binding site of the human placental 5HT transporter (42) . In hSERT, 10 of 31 tyrosine residues (positions 107, 134, 186, 289, 312, 350, 358, 410, 516, and 568) are conserved among all members of the Na+/Cl-cotransporter gene family, including rSERT; one or more of these tyrosines may be required for formation of a cosubstrate ion pocket. hSERT and rSERT are clearly more divergent than rat and human GABA transporters [GAT1 (43) .1-1 ------sequence elements in the primary transcripts of 5HT transporters perhaps affecting RNA stability or translational efficiency. In comparisons of hSERT amino acid sequence with other human and rodent members of the Na+/Cl-cotransporter gene family, hSERT is most closely related to the human norepinephrine transporter (48% amino acid identity), with which it shares antagonism by tricyclic antidepressants, and the rat dopamine transporter (44% identity), which, like the norepinephrine transporter, also binds cocaine. Other family members exhibit 35-39% identity.
N I T W T L H S T S P A E E F Y T R H V L O I H
To investigate the pattern of 5HT transporter expression in human tissues, RNA hybridizations were performed with the hSERT cDNA probe at high stringency. Unlike the rodent 5HT transporter, which appears to be encoded by a single transcript in the central nervous system and peripheral tissues (9, 10), hSERT hybridizations conducted at high stringency recognized multiple RNAs in human placenta and lung (this report) and in the human placental JAR cell line (S.R., unpublished data). Thus, three hybridizing RNAs of 6.8, 4.9, and 3.0 kb were detected in poly(A)+ RNA from human placenta, which contains syncytiotrophoblasts, known to exhibit antidepressant-and cocaine-sensitive 5HT transport (12, 17) , but not in human skeletal muscle, liver, heart, and kidney, tissues lacking the 5HT carrier (Fig. 4A) . Multiple hybridizing RNAs have also been observed in human lung, wherein endothelial cells express an imipramine-sensitive 5HT transporter (13) . The absence of 5HT transporter transcripts in total human brain mRNA hybridizations is most likely a result of small quantities of midbrain and brainstem RNA in the commercial preparations that we used for hybridizations. Similar results are obtained with hybridizations of total rat brain mRNA (9), requiring regional dissections to enrich for target sequences.
Platelet and brain plasma membrane 5HT transporter sites and/or uptake have been reported to be diminished selectively in nonmedicated individuals suffering from affective disorders (21) (22) (23) , although this is not a universal finding and the lack of absolute specificity of radiolabeled imipramine for the 5HT transporter further confounds interpretations (6).
Studies of affective disorders among siblings, family members, twins, and orphans suggest a genetic component underlying depression (46) . A precise segregation of any affective disorder with chromosomal markers has yet to be achieved, although candidate loci on chromosomes 11 and X have been proposed (46) . To begin an evaluation of the role alterations in the 5HT transporter gene may play in human disease, we mapped the human chromosomal location of the 5HT carrier by a combination of somatic cell hybrid DNA analyses and chromosomal in situ hybridizations. Southern blot analysis of 19 human and rodent somatic cell hybrids mapped the 5HT transporter gene to human chromosome 17. The human cDNA probe detected two mouse-, hamster-, and human-specific fragments of 6.6 and 5.8 kb, 14 and 8.3 kb, and 15 and 5.3 kb, respectively (data not shown). As only 90 bp precede the single internal EcoRI site of our hSERT cDNA probe, the two large hybridizing EcoRI fragments most likely arise from a human 5HT transporter gene interrupted by one or more introns. Hybridization to a panel of mouse-human and hamster-human somatic cell hybrids revealed that both human fragments specifically segregate with chromosome 17. In situ hybridization confirmed the localization of the gene to chromosome 17. Of 137 grains in 100 cells analyzed, 23 were located at 17q11.1-17q12, with highest grain density at 17q11.2 (Fig. 4B) . No other chromosomal site was labeled above background (1-2 grains). In future studies it should be possible to evaluate the degree to which natural variation or defects in the 5HT transporter gene segregate with human neuropsychiatric disturbances, defects in placental or vascular physiology, or differential sensitivity to medications and addictive substances.
